Best payment processors for TRT telemed operators in 2026

TRT telemedicine is unlike other high-risk verticals because it splits naturally into two payment flows. The telemed subscription (consultation + membership) can often be underwritten by mainstream processors. The dispensing pharmacy (actual compound delivery) requires specialty underwriting.

Operators who structure this correctly get clean Stripe processing on the front end and compliant pharmacy-specific processing on the fulfillment side. Operators who conflate them end up on the wrong side of acquirer acceptable use policies and get closed.

The two-layer structure

Layer 1 — telemed subscription

Membership fee, consultation fee, follow-up visits. Service revenue for the telemedicine provider. Not the physical product. This layer is eligible for:

• Stripe — approves telemed subscription if marketing is clean (membership for men's health, not "buy testosterone here").
• Square — similar, with MCC 8099 (medical services).
• Braintree — approves most telemed models.
• Fiserv / Elavon / Global Payments — standard healthcare services pricing applies.

Rate: 2.9% + $0.30 flat-rate aggregator or 2.4-2.9% effective on interchange-plus. Reserve usually zero or 2-4% for operators with clean history.

Layer 2 — pharmacy dispensing

Compounded testosterone, hCG, anastrozole, GLP-1s, other prescription items. This layer requires:

• Licensed dispensing pharmacy (503A compounding or retail)
• Pharmacy-specific MCC (5122)
• Pharmacy-eligible acquirer (most aggregators decline retail pharmacy)

Options for pharmacy processing:

• Elavon Pharmacy Program — direct pharmacy underwriting.
• TSYS Pharmacy — similar.
• Worldpay Pharmacy — specialty pharmacy underwriting.
• Specialty high-risk ISOs — if your compounding pharmacy doesn't pass the direct acquirer review, high-risk ISOs place compounding pharmacies case-by-case.

The "all-in-one" trap

Operators new to TRT often try to process the full basket (subscription + compound) on one merchant account. Problems:

• Aggregators decline on the pharmacy piece and close the whole account.
• Specialty pharmacy acquirers price the full basket at pharmacy rates (higher than telemed).
• Chargeback handling differs between service (telemed) and product (pharmacy) — they need different representment templates.

The clean structure: telemed platform processes subscriptions on one merchant account, pharmacy processes product on another, data flows between them through your back-end order system. The two accounts never overlap in underwriting.

Subscription dunning in TRT

TRT memberships typically recur monthly at $79-$299. Failed recurring charges are costly — a failed retention means missed pharmacy revenue too.

Must-have infrastructure:

• Account updater — recovers 40-60% of reissued cards.
• Network tokenization — higher recovery rate than Account Updater alone.
• Smart retry scheduling — 3-4 attempts over 7-14 days is standard; more aggressive triggers decline.
• Pre-dunning outreach — SMS + email 3 days before retry, reminding patient of their script.

Full playbook: subscription dunning recovery.

Chargeback patterns unique to TRT

• "I cancelled but was charged" — most common. Mitigate with clear cancel flow, confirmation emails, one-click cancel in membership portal.
• "Didn't authorize pharmacy charge" — happens when pharmacy bills separately from subscription. Clear pre-billing emails and descriptor alignment critical.
• "Quality issue with compound" — pharmacy chargeback. Representment requires pharmacy-specific evidence: batch records, shipping proof, patient communication logs.

Operators running split telemed + pharmacy accounts need distinct representment templates for each flow. Compelling evidence differs.

Multi-brand TRT operators

A growing pattern in 2026: one platform operates men's TRT, women's HRT, peptide stacks, and weight-loss GLP-1s under separate consumer brands. Structurally:

• One telemed platform underwrites the subscription side.
• One dispensing pharmacy fulfills across brands.
• Brands differentiate on marketing + descriptors but share infrastructure.

Parent merchant account with brand-preserved descriptors is the cleanest fit. Each brand shows on the statement with its own descriptor; underwriting and reserve happen at the platform level. See TRT/HRT operator playbook and telemed-compounding playbook.

Compliance requirements by layer

Telemed layer

• HIPAA compliance (BAA with processor is a nice-to-have, not required)
• State telemedicine licensure tracking
• Patient consent + record-keeping

Pharmacy layer

• DEA registration if controlled substances
• State pharmacy licensure (each ship-to state)
• 503A compounding compliance if compounding
• Prescription verification logs

Acquirer underwriting audits verify these. Missing documentation = account closure.

What not to do

• Don't process pharmacy revenue through a telemed service MCC. Miscoding is a fast path to account closure.
• Don't combine telemed and pharmacy on one MID unless your acquirer explicitly underwrites both.
• Don't run GLP-1 compounding through a card aggregator — regulatory heat on compounding GLP-1s is high in 2026.
• Don't market with "buy testosterone online" copy — fastest way to trigger acquirer compliance review.

What to do next

Single-brand TRT operator: Stripe for the telemed membership, Elavon Pharmacy Program for the dispensing pharmacy. Clean, compliant, 2 underwriting relationships. Recommended even if it seems more complex than one account.

Multi-brand operator (2+ consumer brands under one platform): parent-account structure with orchestration across brands. The 12-question application covers most of the structural questions in the first conversation.